Pneumonia severity index

From Citizendium
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

The pneumonia severity index (PSI) is a clinical prediction rule to estimate the probability of complications among patients with community acquired pneumonia.[1]

The accuracy of the PSI has been independently validated by other researchers.[2]

Patients with PSI Risk groups I-III can usually be treated as an outpatient.[3]

A randomized controlled trial found that use of the PSI to guide management of community acquired pneumonia improved medical care by reducing resource consumption without reducing quality of care.[4]

Removing the effect of age may improve accuracy.[5]

The pneumonia severity index has been compared to the CURB-65 in predicting mortality.[2]

References

  1. Fine MJ, Auble TE, Yealy DM, et al (1997). "A prediction rule to identify low-risk patients with community-acquired pneumonia". N. Engl. J. Med. 336 (4): 243–50. PMID 8995086[e]
  2. 2.0 2.1 Aujesky D, Auble TE, Yealy DM, et al (2005). "Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia". Am. J. Med. 118 (4): 384-92. DOI:10.1016/j.amjmed.2005.01.006. PMID 15808136. Research Blogging.
  3. Carratalà J, Fernández-Sabé N, Ortega L, et al (February 2005). "Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients". Ann. Intern. Med. 142 (3): 165–72. PMID 15684204[e]
  4. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG (2000). "A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin". JAMA 283 (6): 749-55. PMID 10683053[e]
  5. Chen JH, Chang SS, Liu JJ, Chan RC, Wu JY, Wang WC et al. (2010). "Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjects.". Thorax 65 (11): 971-7. DOI:10.1136/thx.2009.129627. PMID 20965934. Research Blogging.

External links